BioCan Novel Respi, kennel cough (1 Dose)

Composition:
Live attenuated Bordetella bronchiseptica strain MSLB 3096 108.0–109.8 CFU*
Live attenuated Canine parainfluenza Type 2 virus, strain CPiV-2 Bio 15 103.5–105.8 CCID50**
*CFU: Colony forming unit
**CCID50: Cell culture infectious dose 50%

Target species: Dogs.

Indications:
Active immunisation of dogs against kennel cough from 3 weeks of age:
To reduce clinical signs and bacterial shedding after infection with Bordetella bronchiseptica.
To reduce clinical signs and viral shedding after infection with canine parainfluenza virus.

Dosage and route of administration: Intranasal instillation.

Refrigerated drugs can't be returned or exchanged.

تحصين حي مُضعف يُعطى عبر الأنف ضد بكتيريا بوردتيلا برونشيبتكا وفيروس البارا إنفلونزا الكلبي (سعال الكلاب) ابتداءً من عمر 3 أسابيع.

لا يمكن إرجاع أو استبدال الأدوية المبردة.